Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis

J Nanobiotechnology. 2023 Aug 17;21(1):271. doi: 10.1186/s12951-023-02058-z.

Abstract

The development of atherosclerosis (AS) is closely linked to changes in the plaque microenvironment, which consists primarily of the cells that form plaque and the associated factors they secrete. The onset of inflammation, lipid deposition, and various pathological changes in cellular metabolism that accompany the plaque microenvironment will promote the development of AS. Numerous studies have shown that oxidative stress is an important condition that promotes AS. The accumulation of reactive oxygen species (ROS) is oxidative stress's most important pathological change. In turn, the effects of ROS on the plaque microenvironment are complex and varied, and these effects are ultimately reflected in the promotion or inhibition of AS. This article reviews the effects of ROS on the microenvironment of atherosclerotic plaques and their impact on disease progression over the past five years and focuses on the progress of treatment strategies based on scavenging ROS of nanoparticles for AS. Finally, we also discuss the prospects and challenges of AS treatment.

Keywords: Atherosclerosis; Nanoparticles; Scavenging ROS; Treatment strategies.

Publication types

  • Review

MeSH terms

  • Atherosclerosis* / drug therapy
  • Humans
  • Nanoparticles*
  • Oxidative Stress
  • Plaque, Amyloid
  • Plaque, Atherosclerotic* / drug therapy
  • Reactive Oxygen Species

Substances

  • Reactive Oxygen Species